Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, has expanded its molecular portfolio of quality controls with the launch of two new Exact Diagnostics products: Bulk Urine Negative and Bulk CSF Negative. Both are matrices designed for spike-in or dilution purposes as well as to be used with molecular assays to monitor their intra- and inter-run performance. Â
Molecular portfolio may also help in the detection of errors in laboratory testing procedures, including potential contamination events.Â
The Exact Diagnostics Bulk Urine Negative is intended to be validated as an independent external quality run control to monitor the absence of Adenovirus (ADV), BK virus (BKV), Candida auris (C. auris), Chlamydia trachomatis (CT), Cytomegalovirus (CMV), John Cunningham virus (JCV), Mycoplasma genitalium (MG), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Zika virus (ZKV) in various molecular assays. Â
The Exact Diagnostics Bulk CSF Negative is an independent external quality run control intended to monitor the absence of Anaplasma phagocytophilum, Babesia microti, Bartonella quintana, Borrelia burgdorferi, Ehrlichia chaffeensis, Enterovirus (EV), Herpes Simplex Virus-1 (HSV- 1), Herpes Simplex Virus-2 (HSV-2), and Varicella Zoster Virus (VZV) in various molecular assays.
These two new additions to Bio-Rad’s family of negative run controls and matrices in its molecular portfolio, which also includes the Exact Diagnostics Negative Run Control & Exact Diagnostics Bulk Negative (plasma), Exact Diagnostics STI Negative Run Control, Exact Diagnostics Synthetic Negative Run Control and Exact Diagnostics HAI Negative Run Control, the last three having been released late last year. Â
Bio-Rad’s negative run controls and matrices enable laboratories to capture run-to-run, day-to-day, instrument-to-instrument, operator-to-operator, and lot-to-lot variations of their molecular assays. They can also be used to train laboratory operators and evaluate proficiency. Another application is the spike-in and dilution of positive specimens or analyte-containing materials for purposes such as assay validation and verification. Â
Both these new products are available now. Visit qcnet.com/molecular to learn more about the Exact Diagnostics portfolio.Â
Featured Image: Exact Diagnostics Bulk Urine Negative is intended to be validated as an independent external quality run control to monitor the absence of Adenovirus (ADV), BK virus (BKV), Candida auris (C. auris), Chlamydia trachomatis (CT), Cytomegalovirus (CMV), John Cunningham virus (JCV), Mycoplasma genitalium (MG), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Zika virus (ZKV) in various molecular assays. Photo: Bio-Rad